| abstract |
Described herein are methods and compositions for treating autoimmune diseases. Aspects of the methods described herein involve, in part, administering to a subject an agent targeting CXCR6. Another aspect of the methods described herein involves, in part, administering to a subject an agent that inhibits SerpinB1. |